CymaBay Therapeutics Inc.

Historical 13F Holders

Symbol
CBAY
CUSIP
23257D103
All holders as of
Q1 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 2 650 $21.1 k
2023 Q4 233 118 M $2.78 B
2023 Q3 217 108 M $1.61 B
2023 Q2 158 92.9 M $1.02 B
2023 Q1 151 89.1 M $777 M
2022 Q4 130 65.6 M $406 M
2022 Q3 110 62.3 M $218 M
2022 Q2 113 63.0 M $186 M
2022 Q1 128 65.5 M $215 M
2021 Q4 128 63.9 M $216 M
2021 Q3 122 46.4 M $169 M
2021 Q2 121 52.2 M $227 M
2021 Q1 137 55.4 M $252 M
2020 Q4 161 57.8 M $332 M
2020 Q3 129 59.1 M $428 M
2020 Q2 127 59.9 M $209 M
2020 Q1 108 58.7 M $88.7 M
2019 Q4 121 59.2 M $116 M
2019 Q3 144 64.1 M $328 M
2019 Q2 148 67.8 M $486 M
2019 Q1 152 69.1 M $918 M
2018 Q4 137 58.9 M $463 M
2018 Q3 141 56.7 M $627 M
2018 Q2 123 56.4 M $757 M
2018 Q1 111 48.7 M $629 M
2017 Q4 82 34.1 M $314 M
2017 Q3 68 30.6 M $246 M
2017 Q2 40 11.3 M $65.3 M
2017 Q1 35 10.6 M $45.6 M
2016 Q4 28 6.99 M $12.0 M
2016 Q3 27 6.53 M $12.7 M
2016 Q2 26 7.12 M $12.4 M
2016 Q1 30 9.07 M $12.2 M
2015 Q4 29 10.8 M $18.1 M
2015 Q3 35 11.9 M $23.0 M
2015 Q2 29 6.73 M $18.2 M
2015 Q1 28 8.20 M $56.7 M
2014 Q4 26 7.66 M $75.3 M
2014 Q3 17 5.20 M $35.6 M